# Trade Mark Journal No.2025/047 21 November 2025

## WO0000001885563 (5)

Office of origin: United States of America

Date of International Registration:13 October 2025
Date of designation in the UK: 13 October 2025

International priority date claimed: 24 April 2025 (United States of America) (99154221)

Class 5
  Therapeutic pharmaceutical preparations for the treatment of neurodegenerative diseases.

Kenai Therapeutics, Inc.

Representative: April Wurster Snell & Wilmer LLP, One East Washington Street,, Suite 2700, Phoenix AZ 85004, UNITED STATES OF AMERICA